Kelyniam Global, Inc. (OTC: KLYG), today announced that the U.S. Food and Drug Administration (FDA) has granted the company authorization to market Custom Craniofacial Implants made from PEEK OPTIMA material. The approval allows Kelyniam to expand its customer base and pursue ENT doctors, plastic surgeons, Facial/Cranial surgeons, military hospitals and government agencies. Patients with maxiofacial...Read More